Your selections:
Development of in silico methodology for siRNA lipid nanoparticle formulations
- Gao, Haoshi, Kan, Stanislav, Cao, Dongsheng, Ji, Yuanhui, Liang, Mingtao, Li, Haifeng, Ouyang, Defang, Ye, Zhuyifan, Feng, Yuchen, Jin, Lei, Zhang, Xudong, Deng, Jiayin, Chan, Ging, Hu, Yuanjia, Wang, Yongjun
c-Myc inactivation of p53 through the pan-cancer lncRNA MILIP drives cancer pathogenesis
Are you sure you would like to clear your session, including search history and login status?